# Professor Aswath Damodaran's blog post on Pfizer's acquisition of Allergan is cited

1 Faculty News November 19, 2015 ![Financial Times logo](/sites/default/files/styles/246w/public/assets/images/uat_025699.jpg?itok=5SpaxEbn)>

Excerpt from [Financial Times](http://www.ft.com/intl/cms/s/0/04534e3a-8ee1-11e5-8be4-3506bf20cc2b.html) -- "'The bottom line is that this looks like a bad deal for the wrong company, at the wrong time and the wrong price,' said [Aswath Damodaran](http://www.stern.nyu.edu/faculty/bio/aswath-damodaran), a finance professor at New York University’s Stern School of Business, in a blog post this week."

[Read more](http://www.ft.com/intl/cms/s/0/04534e3a-8ee1-11e5-8be4-3506bf20cc2b.html)